Loading…
for educational and safety purposes
Diclazepam and Flubromazepam both come up in the same conversations; they overlap on GABA. Diclazepam: Diclazepam is a designer benzodiazepine closely related to diazepam (Valium), essentially a chlorinated version of it. Flubromazepam: Flubromazepam is a designer benzodiazepine notable for an extremely long duration; a single dose can produce effects and residual impairment lasting into multiple days.
Diclazepam is a designer benzodiazepine closely related to diazepam (Valium), essentially a chlorinated version of it. It enhances GABA at the GABA-A receptor to produce sedation, anxiety relief and muscle relaxation, and it is fairly long-acting. As a research chemical it has little human data but shares all the familiar benzodiazepine hazards of dependence, dangerous depressant synergy and hard withdrawal.
Flubromazepam is a designer benzodiazepine notable for an extremely long duration; a single dose can produce effects and residual impairment lasting into multiple days. It enhances GABA at the GABA-A receptor for sedation, anxiety relief and muscle relaxation. Its very long half-life makes accumulation and next-day impairment a particular hazard, on top of the usual benzodiazepine risks.
both fingerprints on one instrument; where the marks line up the two compounds work the same lever, where a slot goes dark only one of them touches it. read straight from each entry's affinity table; nothing here is invented.
Positive allosteric modulator
Positive allosteric modulator
strengths are the entries' qualitative ratings (strong / moderate / weak); Ki and EC50 figures appear where an entry records them.